Literature DB >> 14974281

[Seroprevalence of HBV, HCV, and HIV among blood donors in Irapuato, Mexico].

Miguel Angel Carreto-Vélez1, Teodoro Carrada-Bravo, Angel Martínez-Magdaleno.   

Abstract

OBJECTIVE: To investigate the seroprevalence of viral markers for the human immunodeficiency virus (HIV), and the hepatitis B (HBV) and C (HCV) viruses, in blood donors at the General Hospital No. 2 Family Medicine Unit, of the Mexican Social Security Institute in Irapuato, Mexico.
MATERIAL AND METHODS: A cross-sectional descriptive study. Data was recorded on blood bank forms, and risk factors and illnesses were studied in the 7,056 blood donors at the General Hospital No. 2 Family Medicine Unit, of the Mexican Social Security Institute in Irapuato, Guanajuato, Mexico, over a period of two years (from July 1998 to June 2000). A sample of 4,010 donors was obtained, each of whom underwent serological tests for HBV, HCV and HIV, serotypes 1 and 2, using an enzymatic immunoassay of third generation in serum or human plasma; seroprevalence rate of seropositive donors was calculated and stratified by age and sex.
RESULTS: The combined seroprevalence for HBV, HCV and HIV was 2.5% (101); HCV was 1.14% (46), HBV, 1.12% (45), and HIV, 0.24% (10). In males, HBV was 1.04% (33), HCV 1.07% (34), and HIV, 0.28% (9). In females, HBV was 1.42% (12), HCV was 1.42% (12), and HIV was 0.11% (1). Seropositive males had a 2.4 higher rate as compared to females.
CONCLUSIONS: The seroprevalence of viral markers was greater than that reported in previous studies carried out in Mexico, which suggests that sexual transmission was the principal mechanism of infection; this reflects poor health education and the need to carefully select potential donors. The English version of this paper is available at:http://www.insp.mx/salud/index.html.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14974281

Source DB:  PubMed          Journal:  Salud Publica Mex        ISSN: 0036-3634


  5 in total

1.  A low steady HBsAg seroprevalence is associated with a low incidence of HBV-related liver cirrhosis and hepatocellular carcinoma in Mexico: a systematic review.

Authors:  Sonia Roman; Arturo Panduro; Yadira Aguilar-Gutierrez; Montserrat Maldonado; Maclovia Vazquez-Vandyck; Erika Martinez-Lopez; Bertha Ruiz-Madrigal; Zamira Hernandez-Nazara
Journal:  Hepatol Int       Date:  2008-12-19       Impact factor: 6.047

2.  Seroprevalence of HCV and its co-infection with HBV and HIV among liver disease patients of South Tamil Nadu.

Authors:  Ganesh Kumar Anbazhagan; Sridharan Krishnamoorthy; Thirunalasundari Thiyagarajan
Journal:  World J Hepatol       Date:  2010-01-27

3.  Prevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.S.

Authors:  Emily Faye White; Richard S Garfein; Kimberly C Brouwer; Remedios Lozada; Rebeca Ramos; Michelle Firestone-Cruz; Saida G Pérez; Carlos Magis-Rodríguez; Carlos J Conde-Glez; Steffanie A Strathdee
Journal:  Salud Publica Mex       Date:  2007 May-Jun

4.  Hepatitis B virus infection among inpatients of a psychiatric hospital of Mexico.

Authors:  Cosme Alvarado Esquivel; Miguel Angel Arreola Valenzuela; Miguel Francisco Mercado Suárez; Francisco Espinoza Andrade
Journal:  Clin Pract Epidemiol Ment Health       Date:  2005-07-29

Review 5.  Global View of HIV Prevalence in Prisons: A Systematic Review and Meta-Analysis.

Authors:  Mehdi Sayyah; Fakher Rahim; Gholam Abbas Kayedani; Kiarash Shirbandi; Amal Saki-Malehi
Journal:  Iran J Public Health       Date:  2019-02       Impact factor: 1.429

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.